Biopharmaceutical Downstream Processing
Biopharmaceutical Downstream Processing is a singular academic concept referring to the series of purification and isolation techniques applied after biological production to separate, refine, and formulate biopharmaceuticals from complex mixtures, distinguished from upstream processes by its focus on product recovery and quality assurance through physical, chemical, and biochemical separation methods.
132
Publications
5.2K
Citations
573
Authors
161
Institutions
Publications per year
2017–2026
61
132
Aggregation Stability of a Monoclonal Antibody During Downstream Processing
Paolo Arosio, Giuliano Barolo, Thomas Müller‐Späth et al. · Pharmaceutical Research · 2011 · 119 citations · Full text
Kristin N. Valente, Abraham M. Lenhoff, Kelvin H. Lee · Biotechnology and Bioengineering · 2014 · 103 citations
1–5 of 132
573
7
h-index
6
h-index
5
h-index
Fraunhofer Institute for Molecular Biology and Applied Ecology, Germany
5 publications · 195 citations
5
h-index
5
h-index
1–5 of 573
161
Indian Institute of Technology Delhi
New Delhi, India
6 h-index
18 publications
1.3K citations
Karlsruhe Institute of Technology
Karlsruhe, Germany
6 h-index
19 publications
680 citations
University College London
London, United Kingdom
6 h-index
19 publications
637 citations
RWTH Aachen University
Aachen, Germany
5 h-index
9 publications
337 citations
Fraunhofer Institute for Molecular Biology and Applied Ecology
Schmallenberg, Germany
5 h-index
11 publications
300 citations

Delft University of Technology
Delft, The Netherlands
5 h-index
11 publications
448 citations

Clausthal University of Technology
Clausthal-Zellerfeld, Germany
4 h-index
10 publications
336 citations
Boehringer Ingelheim (Germany)
Ingelheim, Germany
4 h-index
26 publications
583 citations
1–8 of 161
19 publications · 554 citations
17
h-index
17 publications · 1.1K citations
16
h-index
8 publications · 272 citations
8
h-index
6 publications · 365 citations
6
h-index
5 publications · 170 citations
5
h-index
1–5